Related references
Note: Only part of the references are listed.NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Michele Dal Bo et al.
ANNALS OF HEMATOLOGY (2014)
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
Stephan Stilgenbauer et al.
BLOOD (2014)
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia
P. Sportoletti et al.
LEUKEMIA (2014)
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
F. Arruga et al.
LEUKEMIA (2014)
Therapeutic modulation of Notch signalling - are we there yet?
Emma R. Andersson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2013)
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2013)
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia
Giovanni Del Poeta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Dynamic binding of RBPJ is determined by Notch signaling status
David Castel et al.
GENES & DEVELOPMENT (2013)
NOTCH1 mutations in CLL associated with trisomy 12
Veronica Balatti et al.
BLOOD (2012)
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
NOTCH1 mutations in+12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of+12 CLL
Ilaria Del Giudice et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
R. Bomben et al.
LEUKEMIA (2012)
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells
A. Zucchetto et al.
LEUKEMIA (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
Maddalena Paganin et al.
BLOOD REVIEWS (2011)
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Camille Lobry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia
I. Saborit-Villarroya et al.
LEUKEMIA (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Functions of Notch Signaling in the Immune System: Consensus and Controversies
Julie S. Yuan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
Paolo Sportoletti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells
R. Shimizu et al.
LEUKEMIA (2010)
Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation
Takumi Sugimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
Junji Hiraga et al.
BLOOD (2009)
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia
Valter Gattei et al.
BLOOD (2008)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype:: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients
Constantine S. Tam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice
Apostolos Klinakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Notch signalling: a simple pathway becomes complex
Sarah J. Bray
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
HES and HERP families: Multiple effectors of the Notch signaling pathway
T Iso et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
J Golay et al.
BLOOD (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
